NSTM
NovelStem International Corp.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 334 |
Stock Information
| Shares Outstanding | 49.33M |
| Total Debt | $1.93M |
| Cash Equivalents | $90K |
| Net Income | $2.53M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $493K |
| P/E Ratio | 0.20 |
| EPS (TTM) | $0.05 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.48M |
| Income | $2.53M |
| Book/sh | $-0.04 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.04 |
| Current Ratio | 0.05 |
Returns & Margins
| ROA | -74.30% |
Ownership
| Insider Ownership | 58.57% |
| Institutional Ownership | 0.05% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.26 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.02 |
| RSI | 50.00 |
| ATR | 0.0029 |
| Shares Float | 20.44M |
| Short Float | 0.03% |
| Short Ratio | 0.12 |
| Volatility | 2.40 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | -50.00% |
| YTD | +0.00% |
| Year | -66.67% |
| 3 Years | -95.83% |
| 5 Years | -96.67% |
| 10 Years | -95.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.01 | 0 |
| 2026-06-17 | $0.01 | 0 |
| 2026-06-16 | $0.01 | 300 |
| 2026-06-15 | $0.01 | 0 |
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 57,400 |
| 2026-06-08 | $0.03 | 47,300 |
| 2026-06-05 | $0.02 | 23,000 |
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 300 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 500 |
About NovelStem International Corp.
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on NSTM.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $12,000 | $12,000 | $12,000 | $0 |
| Operating Revenue | $12,000 | $12,000 | $12,000 | $0 |
| Expenses | ||||
| Interest Expense | $425,417 | $99,023 | $11,018 | $6,825 |
| Total Expenses | $880,947 | $665,277 | $744,434 | $495,535 |
| Other Income Expense | $-1,777,632 | $-3,132,522 | $310,000 | - |
| Net Non Operating Interest Income Expense | $-425,417 | $-99,023 | $-11,018 | $-6,825 |
| Interest Expense Non Operating | $425,417 | $99,023 | $11,018 | $6,825 |
| Operating Expense | $880,947 | $665,277 | $744,434 | $495,535 |
| General And Administrative Expense | $880,947 | $665,277 | $744,434 | $495,535 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Net Interest Income | $-425,417 | $-99,023 | $-11,018 | $-6,825 |
| Normalized Income | $-1,455,410 | $-1,054,779 | $-1,075,730 | $-1,345,628 |
| Net Income From Continuing And Discontinued Operation | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Total Operating Income As Reported | $-927,922 | $-3,525,799 | $-422,434 | $-495,535 |
| Net Income Common Stockholders | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Net Income | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Net Income Including Noncontrolling Interests | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Net Income Continuous Operations | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Earnings From Equity Interest Net Of Tax | $-161,046 | $-302,479 | $-332,278 | $-843,268 |
| Pretax Income | $-3,071,996 | $-3,884,822 | $-433,452 | $-502,360 |
| Special Income Charges | $-1,687,632 | $-2,872,522 | $310,000 | - |
| Operating Income | $-868,947 | $-653,277 | $-732,434 | $-495,535 |
| Per Share | ||||
| Diluted EPS | $-0.07 | $-0.09 | $-0.02 | $-0.03 |
| Basic EPS | $-0.07 | $-0.09 | $-0.02 | $-0.03 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-868,947 | $-653,277 | $-732,434 | $-495,535 |
| Total Unusual Items | $-1,777,632 | $-3,132,522 | $310,000 | - |
| Total Unusual Items Excluding Goodwill | $-1,777,632 | $-3,132,522 | $310,000 | - |
| EBITDA (Bullshit earnings) | $-2,646,579 | $-3,785,799 | $-422,434 | $-495,535 |
| EBIT | $-2,646,579 | $-3,785,799 | $-422,434 | $-495,535 |
| Diluted Average Shares | $46,881,475 | $46,881,475 | $46,881,475 | $44,259,559 |
| Basic Average Shares | $46,881,475 | $46,881,475 | $46,881,475 | $44,259,559 |
| Diluted NI Availto Com Stockholders | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $58,975 | $2,872,522 | $-310,000 | - |
| Write Off | $1,628,657 | $0 | - | - |
| Gain On Sale Of Security | $-90,000 | $-260,000 | - | - |
| Selling General And Administration | $880,947 | $665,277 | $744,434 | $495,535 |
| Other Gand A | $880,947 | $665,277 | $744,434 | $495,535 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-5,144,375 | $-1,951,533 | $1,932,878 | $2,415,946 |
| Total Assets | $160,111 | $2,254,546 | $2,286,204 | $2,609,148 |
| Total Non Current Assets | $128,240 | $2,167,943 | $2,227,297 | $2,572,166 |
| Non Current Note Receivables | $0 | $250,000 | $0 | - |
| Current Assets | $31,871 | $86,603 | $58,907 | $36,982 |
| Prepaid Assets | $15,272 | $33,540 | $40,561 | $28,316 |
| Receivables | $10,500 | $0 | $12,000 | $0 |
| Accounts Receivable | $10,500 | $0 | $12,000 | $0 |
| Cash Cash Equivalents And Short Term Investments | $6,099 | $53,063 | $6,346 | $8,666 |
| Cash And Cash Equivalents | $6,099 | $53,063 | $6,346 | $8,666 |
| Cash Financial | $6,099 | $53,063 | $6,346 | $8,666 |
| Debt | ||||
| Net Debt | $4,411,913 | $3,521,536 | $282,104 | $91,334 |
| Total Debt | $4,418,012 | $3,574,599 | $288,450 | $100,000 |
| Current Debt And Capital Lease Obligation | $4,418,012 | $250,000 | - | $100,000 |
| Current Debt | $4,418,012 | $250,000 | - | $100,000 |
| Other Current Borrowings | $4,168,012 | $250,000 | - | $100,000 |
| Long Term Debt And Capital Lease Obligation | - | $3,324,599 | $288,450 | - |
| Long Term Debt | - | $3,324,599 | $288,450 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,304,486 | $4,206,079 | $353,326 | $193,202 |
| Total Non Current Liabilities Net Minority Interest | $0 | $3,859,599 | $288,450 | $0 |
| Derivative Product Liabilities | $0 | $535,000 | $0 | - |
| Current Liabilities | $5,304,486 | $346,480 | $64,876 | $193,202 |
| Other Current Liabilities | $650,000 | - | - | - |
| Current Notes Payable | $250,000 | $250,000 | - | - |
| Payables And Accrued Expenses | $236,474 | $96,480 | $64,876 | $93,202 |
| Payables | $167,898 | $54,257 | $21,203 | $49,777 |
| Accounts Payable | $167,898 | $54,257 | $21,203 | $49,777 |
| Equity | ||||
| Common Stock Equity | $-5,144,375 | $-1,951,533 | $1,932,878 | $2,415,946 |
| Total Equity Gross Minority Interest | $-5,144,375 | $-1,951,533 | $1,932,878 | $2,415,946 |
| Stockholders Equity | $-5,144,375 | $-1,951,533 | $1,932,878 | $2,415,946 |
| Retained Earnings | $-296,360,853 | $-293,127,811 | $-288,940,510 | $-288,174,780 |
| Long Term Equity Investment | $128,240 | $1,917,943 | $2,227,297 | $2,572,166 |
| Other | ||||
| Treasury Shares Number | $3,435,197 | $3,435,197 | $3,435,197 | - |
| Ordinary Shares Number | $46,881,475 | $46,881,475 | $46,881,475 | $46,881,475 |
| Share Issued | $50,316,672 | $50,316,672 | $50,316,672 | $46,881,475 |
| Tangible Book Value | $-5,144,375 | $-1,951,533 | $1,932,878 | $2,415,946 |
| Invested Capital | $-726,363 | $1,623,066 | $2,221,328 | $2,515,946 |
| Working Capital | $-5,272,615 | $-259,877 | $-5,969 | $-156,220 |
| Total Capitalization | $-5,144,375 | $1,373,066 | $2,221,328 | $2,415,946 |
| Treasury Stock | $199,754 | $199,754 | $199,754 | $199,754 |
| Additional Paid In Capital | $290,947,417 | $290,907,217 | $290,604,327 | $290,321,665 |
| Capital Stock | $468,815 | $468,815 | $468,815 | $468,815 |
| Common Stock | $468,815 | $468,815 | $468,815 | $468,815 |
| Current Accrued Expenses | $68,576 | $42,223 | $43,673 | $43,425 |
| Investments And Advances | $128,240 | $1,917,943 | $2,227,297 | $2,572,166 |
| Investmentsin Joint Venturesat Cost | $128,240 | $133,709 | $137,011 | $137,011 |
| Investmentsin Associatesat Cost | $0 | $1,784,234 | $2,090,286 | $2,435,155 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-271,964 | $-348,283 | $-182,320 | $-180,928 |
| Operating Activities | ||||
| Operating Cash Flow | $-271,964 | $-348,283 | $-182,320 | $-180,928 |
| Cash Flow From Continuing Operating Activities | $-271,964 | $-348,283 | $-182,320 | $-180,928 |
| Operating Gains Losses | $251,046 | $562,479 | $332,278 | $843,268 |
| Investing Activities | ||||
| Investing Cash Flow | $-250,000 | $-250,000 | $0 | - |
| Cash Flow From Continuing Investing Activities | $-250,000 | $-250,000 | $0 | - |
| Net Other Investing Changes | $-250,000 | $-250,000 | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $475,000 | $645,000 | $180,000 | $100,000 |
| Cash Flow From Continuing Financing Activities | $475,000 | $645,000 | $180,000 | $100,000 |
| Dividend Received Cfo | $0 | $6,875 | $12,591 | $21,290 |
| Other | ||||
| Issuance Of Debt | $475,000 | $645,000 | $280,000 | $100,000 |
| Interest Paid Supplemental Data | $1,922 | $1,248 | $8,320 | $1,073 |
| End Cash Position | $6,099 | $53,063 | $6,346 | $8,666 |
| Beginning Cash Position | $53,063 | $6,346 | $8,666 | $89,594 |
| Changes In Cash | $-46,964 | $46,717 | $-2,320 | $-80,928 |
| Net Issuance Payments Of Debt | $475,000 | $645,000 | $180,000 | $100,000 |
| Net Long Term Debt Issuance | $475,000 | $645,000 | $180,000 | $100,000 |
| Long Term Debt Issuance | $475,000 | $645,000 | $280,000 | $100,000 |
| Change In Working Capital | $147,762 | $50,625 | $-52,571 | $27,376 |
| Change In Payables And Accrued Expense | $139,994 | $31,604 | $-28,326 | $24,457 |
| Change In Accrued Expense | $26,353 | $-1,450 | $248 | $3,751 |
| Change In Payable | $113,641 | $33,054 | $-28,574 | $20,706 |
| Change In Account Payable | $113,641 | $33,054 | $-28,574 | $20,706 |
| Change In Prepaid Assets | $18,268 | $7,021 | $-12,245 | $2,919 |
| Change In Receivables | $-10,500 | $12,000 | $-12,000 | $0 |
| Changes In Account Receivables | $-10,500 | $12,000 | $-12,000 | $0 |
| Other Non Cash Items | $393,413 | $2,916,149 | $8,450 | - |
| Stock Based Compensation | $40,200 | $302,890 | $282,662 | $272,766 |
| Asset Impairment Charge | $2,128,657 | $0 | - | - |
| Earnings Losses From Equity Investments | $161,046 | $302,479 | $332,278 | $843,268 |
| Gain Loss On Investment Securities | $90,000 | $260,000 | - | - |
| Net Income From Continuing Operations | $-3,233,042 | $-4,187,301 | $-765,730 | $-1,345,628 |
| Change In Other Current Assets | - | $0 | $0 | - |
| Repayment Of Debt | - | - | $-100,000 | - |
| Long Term Debt Payments | - | - | $-100,000 | - |
Fetched: 2026-02-02